>
Organization
Eisai Co., Ltd.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed

News on Eisai Co., Ltd.

... PR Newswire Eisai Co., Ltd. (CEO: Haruo Naito, "Eisai") and Purdue Pharma L.P. (President and CEO: ...
... Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, 'Eisai') announced today that the application ...
... Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, 'Eisai') announced today that presentations on ...
... TOKYO and STAMFORD - Eisai Co., Ltd. (CEO: Haruo Naito, 'Eisai') and Purdue Pharma L.P. (President and CEO: ...
... Eisai and its partner Purdue Pharma have submitted new drug application to the ...
... PR Newswire Eisai Co., Ltd. (CEO: Haruo Naito, "Eisai") and Purdue Pharma L.P. (President and CEO: ...
... Global Xerostomia Therapeutics Market 2019-2023 - Key Vendors are Colgate-Palmolive, Daiichi Sankyo, Eisai, GlaxoSmithKline & Orahealth - ResearchAndMarkets.com ...
... Global Sarcoma Therapeutics Market 2019-2023 - Key Players are Bayer, Eisai, Eli Lilly, Johnson & Johnson and Novartis - ResearchAndMarkets.com ...
... Market, 2018-2022" report has been added to ResearchAndMarkets.com's offering. Developed by Eisai Co. Ltd., Mecobalamin (trade name: Methycobal) was launched in Japan in the mid-1980s ...
... around the Sunda Strait in Indonesia. In response to this disaster, Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito) has decided to offer a donation ...
Subscribe now for full coverage on Eisai Co., Ltd.
Start My Free Trial